Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EarlySense developed a proprietary contact-free continuous patient monitoring platform that uses a sensor placed under the mattress to track heart rate, respiratory rate, and motion. The system provides real-time data to clinicians for early detection of patient deterioration and has demonstrated clinical benefits such as reduced code blue events by up to 86%, ICU days by up to 45%, hospital readmissions by up to 19%, falls by up to 47%, and pressure ulcers by up to 75%. The technology received FDA clearance in the US and CE mark in Europe. In February 2021, EarlySense was acquired by Hillrom.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EarlySense.